The United States was among the biggest backers of the AstraZeneca COVID vaccine, but a series of blunders by the company eroded American authorities’ confidence and have delayed rollout in the world’s hardest-hit country. The British-Swedish drugmaker was on the backfoot Tuesday, vowing to release more data “within 48 hours” after the US National Institute